ResultsIQ › Latest results › Aptus Pharma Ltd
Aptus Pharma Ltd (APPL) quarterly results
NSE: APPL · BSE: 544529
AI summary: Results deck, Q1 FY27
Results deck of 21 Aug 2026, summarised by AI from the filing.
FY26 revenue from operations ₹46.57 cr, up 89.7%, with PAT ₹4.62 cr, up 49.0%.
Key takeaways
- FY26 revenue Revenue from operations ₹46.57 cr (FY25: ₹24.56 cr, +89.7%).
- H2 revenue H2 FY26 revenue ₹32.20 cr vs H1 FY26 ₹14.38 cr.
- Growth driver Asset-light model with WHO-GMP contract manufacturers redirects resources to sales and brand building.
- Margin risk Gross profit margin fell to 54.1% in FY26 from 63.2% in FY25.
Aptus Pharma Ltd earnings call, investor presentation and press release summaries
- Q1 FY27: Results deck (21 Aug 2026)
- Q4 FY26: Results press release (28 Apr 2026)
- Other events: Strategy deck (7 Feb 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.